ANAVEX LIFE SCIENCES CORP.

Nasdaq:AVXL

Biological Products, (No Diagnostic Substances)·NEW YORK, NY

CEO

Missling Christopher U

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	12/31/25	2/9/26	→
10-K	FY 2025	9/30/25	11/25/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-Q	Q4 2024	12/31/24	2/12/25	→
10-K	FY 2024	9/30/24	12/23/24	→
↓

Earnings Releases (8-K)

4 shown

Filed	Period
2/9/26	Q2 FY2026	→
11/25/25	Q1 FY2026	→
5/9/24	Q3 FY2024	→
12/28/20	Q1 FY2021	→

News (8-K)

76 shown

Filed	Type	Description
2/25/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/14/25	Other	Other Events	→
7/28/25	Agreement	Entry into a Material Definitive Agreement	→
7/3/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/13/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
7/30/24	Other	Termination of a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
7/25/25	424B5	424B5	→
7/14/25	S-3	S-3	→
4/25/25	ARS	ARS	→
7/29/24	S-3	S-3	→
2/7/23	424B5	424B5	→
6/10/22	S-8	S-8	→
↓

Filing History(576 filings)

TypeDateAccessionPeriodSize

8-K

Feb 25, 2026

0001731122-26-000305FORM 8-K

Feb 20, 2026

198.9 KB

10-Q

Feb 9, 2026

0001731122-26-000200FORM 10-Q

Dec 31, 2025

3.2 MB

8-K

Feb 9, 2026

0001731122-26-000193FORM 8-K

Feb 9, 2026

263.1 KB

Jan 9, 2026

0001731122-26-000036

Jan 6, 2026

5.6 KB

Jan 9, 2026

0001731122-26-000035

Jan 6, 2026

5.6 KB

10-K

Nov 25, 2025

0001731122-25-001596FORM 10-K

Sep 30, 2025

6.8 MB

8-K

Nov 25, 2025

0001731122-25-001591FORM 8-K

Nov 25, 2025

304.3 KB

8-K

Nov 14, 2025

0001731122-25-001536FORM 8-K

Nov 14, 2025

202.1 KB

Oct 3, 2025

0001731122-25-001355

Oct 2, 2025

5.6 KB

Oct 3, 2025

0001731122-25-001354

Oct 2, 2025

5.6 KB

Sep 12, 2025

0001731122-25-001246

Sep 11, 2025

8.7 KB

Aug 22, 2025

0001731122-25-001168

Aug 20, 2025

5.6 KB

Aug 22, 2025

0001731122-25-001167

Aug 20, 2025

5.6 KB

10-Q

Aug 12, 2025

0001731122-25-001105FORM 10-Q

Jun 30, 2025

3.3 MB

8-K

Jul 28, 2025

0001731122-25-001033FORM 8-K

Jul 25, 2025

465.7 KB

424B5

Jul 25, 2025

0001731122-25-001025FORM 424B5

—

503.5 KB

EFFECT

Jul 23, 2025

9999999995-25-002330

—

1.8 KB

CORRESP

Jul 21, 2025

0001731122-25-001001

—

6.9 KB

UPLOAD

Jul 21, 2025

0000000000-25-007655

—

39.3 KB

S-3

Jul 14, 2025

0001731122-25-000973FORM S-3

—

222.5 KB

8-K

Jul 3, 2025

0001731122-25-000935FORM 8-K

Jul 3, 2025

266.2 KB

8-K

Jun 13, 2025

0001731122-25-000878FORM 8-K

Jun 10, 2025

218.1 KB

Jun 9, 2025

0001731122-25-000837

Jun 5, 2025

8.7 KB

10-Q

May 13, 2025

0001731122-25-000724FORM 10-Q

Mar 31, 2025

3.2 MB

Apr 30, 2025

0001731122-25-000655

Apr 28, 2025

5.6 KB

25 filings shown

Filed	Form	Description
4/25/25	DEFA14A	FORM DEFA14A	→
4/25/25	DEF 14A	DEF 14A	→
5/6/24	DEFA14A	FORM DEFA14A	→
5/6/24	DEF 14A	DEF 14A	→
4/4/23	DEFA14A	FORM DEFA14A	→
4/4/23	DEF 14A	DEF 14A	→
↓

ANAVEX LIFE SCIENCES CORP.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(576 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/9/26	4	4	→
1/9/26	4	4	→
10/3/25	4	4	→
10/3/25	4	4	→
9/12/25	4	4	→
8/22/25	4	4	→
↓

Filed	Form	Description
7/23/25	EFFECT	EFFECT	→
3/28/24	144	144	→
6/28/23	144	144	→
9/20/19	EFFECT	EFFECT	→
9/17/19	POS AM	FORM POS AM	→
9/16/19	AW	AW	→
↓